Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · IEX Real-Time Price · USD

237.83

+1.13 (0.48%)

At close: Jul 19, 2024, 4:00 PM

241.84

+4.01 (1.69%)

Pre-market: Jul 22, 2024, 9:24 AM EDT

Alnylam Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2003
Net Income	-332.08	-440.24	-1,131.16	-852.82	-858.28	-886.12	Upgrade
Depreciation & Amortization	96.44	97.03	85.55	89.69	74.44	54.37	Upgrade
Share-Based Compensation	227.08	221.68	230.65	165.72	139.87	174.84	Upgrade
Other Operating Activities	197.67	225.69	273.68	-44.28	29.01	378.48	Upgrade
Operating Cash Flow	189.12	104.16	-541.27	-641.69	-614.96	-278.43	Upgrade
Capital Expenditures	-61.29	-62.21	-72.06	-76.37	-70.36	-140.16	Upgrade
Change in Investments	-262.02	-269.7	246.11	-192.73	-359.86	-270.52	Upgrade
Other Investing Activities	-4.44	-4.44	-4.69	-4.2	-5.3	-7	Upgrade
Investing Cash Flow	-327.75	-336.35	169.35	-273.3	-435.52	-417.68	Upgrade
Share Issuance / Repurchase	130.95	147.46	259.36	246.27	299.98	853.18	Upgrade
Debt Issued / Paid	0	0	135.39	500	200	0	Upgrade
Other Financing Activities	23.72	24.67	31	500.85	495	-30	Upgrade
Financing Cash Flow	154.67	172.13	425.75	1,247	994.98	823.18	Upgrade
Exchange Rate Effect	-5.73	6.39	-7.43	-9.02	4.92	-0.08	Upgrade
Net Cash Flow	10.31	-53.67	46.4	323.11	-50.58	127	Upgrade
Free Cash Flow	127.82	41.95	-613.33	-718.07	-685.32	-418.58	Upgrade
Free Cash Flow Margin	6.38%	2.29%	-59.12%	-85.05%	-139.05%	-190.48%	Upgrade
Free Cash Flow Per Share	1.01	0.34	-5.04	-6.06	-5.96	-3.83	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).